Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allogeneic hematopoietic cell transplantation for older patients
Richard J. Lin, Andrew Artz
Hematology (2021) Vol. 2021, Iss. 1, pp. 254-263
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Relationship between age, conditioning intensity, and outcome after allografting in adults age ≥60 years with AML
Phuong Vo, Brenda M. Sandmaier, Megan Othus, et al.
Bone Marrow Transplantation (2025)
Open Access | Times Cited: 1
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Muhammad Bilal Abid, Noel Estrada-Merly, Mei‐Jie Zhang, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 10, pp. 611-618
Open Access | Times Cited: 19
How I reduce and treat posttransplant relapse of MDS
Alain Mina, Peter L. Greenberg, H. Joachim Deeg
Blood (2024) Vol. 143, Iss. 14, pp. 1344-1354
Closed Access | Times Cited: 5
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial
Fabio Efficace, Michal Kiciński, Corneel Coens, et al.
Blood (2024) Vol. 144, Iss. 5, pp. 541-551
Open Access | Times Cited: 5
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia
Muhammad Bilal Abid, Noel Estrada‐Merly, Mei‐Jie Zhang, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 9, pp. 578.e1-578.e9
Open Access | Times Cited: 13
Allogeneic Haematopoietic Stem Cell Transplantation Using Reduced‐Intensity Fludarabine, Busulfan and Anti‐T‐Lymphocyte Globulin With Strategic Donor Lymphocyte Infusion in Older Patients With Myeloid Malignancy
C P Armstrong, Eibhlin Conneally, Catherine Flynn, et al.
European Journal Of Haematology (2025)
Open Access
The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients
Sarah Wall, Rebecca L. Olin, Vijaya Raj Bhatt, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 10, pp. 632.e1-632.e10
Open Access | Times Cited: 9
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome
Samia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, et al.
Bone Marrow Transplantation (2023) Vol. 59, Iss. 1, pp. 101-106
Closed Access | Times Cited: 9
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study
Jan Frederic Weller, Claudia Lengerke, Jürgen Finke, et al.
Haematologica (2023) Vol. 109, Iss. 2, pp. 431-443
Open Access | Times Cited: 7
Transplantation and Cellular Therapy for Older Adults—The MSK Approach
Richard J. Lin, Parastoo B. Dahi, Beatriz Korc‐Grodzicki, et al.
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 2, pp. 82-91
Open Access | Times Cited: 2
The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia–lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular Therapy
Shigeo Fuji, Yoshitaka Inoue, Junya Makiyama, et al.
Bone Marrow Transplantation (2023) Vol. 58, Iss. 6, pp. 729-731
Closed Access | Times Cited: 4
Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician
Catherine Lai, Rahul S. Bhansali, Eric Kuo, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 4
Generation of Human Regulatory Dendritic Cells from Cryopreserved Healthy Donor Cells and Hematopoietic Stem Cell Transplant Recipients
Sabrina M Scroggins, Annette J. Schlueter
Cells (2023) Vol. 12, Iss. 19, pp. 2372-2372
Open Access | Times Cited: 4
Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies
Idoroenyi Amanam, Salman Otoukesh, Monzr M. Al Malki, et al.
Hematology (2023) Vol. 2023, Iss. 1, pp. 164-170
Closed Access | Times Cited: 4
Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain
Pashna N. Munshi, Shannon R. McCurdy
American Journal of Hematology (2024) Vol. 99, Iss. 5, pp. 922-937
Closed Access | Times Cited: 1
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years
Shai Shimony, Geoffrey Fell, Evan C. Chen, et al.
Blood Advances (2023) Vol. 7, Iss. 18, pp. 5354-5358
Open Access | Times Cited: 3
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies
Sharmila Raghunandan, Muna Qayed, Benjamin Watkins, et al.
Bone Marrow Transplantation (2023) Vol. 58, Iss. 11, pp. 1264-1266
Open Access | Times Cited: 2
Health professionals’ perceptions of prehabilitation before haematopoietic cell transplantation to optimise candidacy in older adults
Emer Guinan, C. E. M. Heuston, Gráinne Sheill, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 7
Open Access
Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress?
Dina Mahdi, Jessica Spiers, Alexandros Rampotas, et al.
British Journal of Haematology (2023) Vol. 203, Iss. 2, pp. 169-181
Closed Access | Times Cited: 1
Assistência à saúde de pacientes com neoplasias hematológicas: revisão integrativa
Tássia Regine de Morais Alves, Luana Dantas Vale, Jéssica Cristina Alves de Melo, et al.
Contribuciones a las Ciencias Sociales (2024) Vol. 17, Iss. 4, pp. e5289-e5289
Open Access
Zelluläre Therapien im Alter: Everything, everywhere, all at once?
Wiebke Rösler
InFo Hämatologie + Onkologie (2024) Vol. 27, Iss. 7-8, pp. 20-26
Closed Access
Venous Thromboembolism Prophylaxis after hematopoietic cell transplantation: still a challenge for haematologists and haemostasiologists
Paola Ranalli, Hugo Ten Cate
Thrombosis and Haemostasis (2024) Vol. 125, Iss. 02, pp. 163-165
Open Access
Relationship Between Age, Conditioning Intensity, and Outcome After Allografting in Adults Age ≥60 Years with AML
Phuong Vo, Brenda M. Sandmaier, Megan Othus, et al.
Research Square (Research Square) (2024)
Open Access
Allogeneic Hematopoietic Cell Transplantation in Elderly Patients in a Latin American Country: Analysis of 11 Years of Data from the Brazilian Registry SBTMO/CIBMTR
Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Nelson Hamerschlak, et al.
Transplantation and Cellular Therapy (2024) Vol. 31, Iss. 2, pp. 79.e1-79.e9
Closed Access
Role of Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia in the Contemporary Era
Omer Jamy, Talha Badar
Cancers (2024) Vol. 17, Iss. 1, pp. 104-104
Open Access
Page 1 - Next Page

Scroll to top